Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese Distributor Of Counterfeit Pharmaceuticals Sentenced To Prison For 78 Months, $1.286 Million In Restitution To Pfizer And Lilly

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - The 5th Circuit U.S. Court of Appeals re-sentenced Kevin Xu, owner of Pacific Orient International, a pharmaceutical distributor in China, to prison for conspiring to distribute counterfeit and misbranded drugs, United States Attorney José Angel Moreno announced April 23
Advertisement

Related Content

IFPMA Outlines Plan For Fighting Counterfeit Drugs
IFPMA Outlines Plan For Fighting Counterfeit Drugs
China's SFDA Launches Inspection Campaign To Ferret Out Fake Drugs Sold In Retail Outlets
China's SFDA Launches Inspection Campaign To Ferret Out Fake Drugs Sold In Retail Outlets
Lack Of Globally Accepted Definition of “Counterfeit Drug” Hurts U.S. FDA, Department Of Commerce Drive To Tackle Problem
Counterfeit Drugs Produced In China Still Threaten Chinese, U.S., Global Consumers
Advertisement
UsernamePublicRestriction

Register

SC074942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel